SEP 10, 2026 · JOURNAL ARTICLE
Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer
Frontiers in Immunology
A single-center retrospective cohort study with moderate internal discrimination (AUROC 0.731 corrected) identifying early biomarker changes associated with rare ICI-induced myasthenia gravis; findings require external validation before clinical use.
Reported
Baseline cohort sample size826
Baseline events (definite or prob…27
Day-21 cohort sample size782